Jinhe Biotechnology CO., LTD. (002688.SZ)
CNY 7.18
(9.95%)
CNY 7.18
(9.95%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 104.73 Million CNY | -48.92% |
| 2022 | 205.02 Million CNY | -9.08% |
| 2021 | 225.51 Million CNY | 3.36% |
| 2020 | 218.18 Million CNY | -31.57% |
| 2019 | 318.86 Million CNY | 17.29% |
| 2018 | 271.84 Million CNY | 33.02% |
| 2017 | 204.36 Million CNY | -2.31% |
| 2016 | 209.2 Million CNY | 73.01% |
| 2015 | 120.91 Million CNY | 44.97% |
| 2014 | 83.41 Million CNY | -21.88% |
| 2013 | 106.77 Million CNY | 7.76% |
| 2012 | 99.08 Million CNY | 13.45% |
| 2011 | 87.33 Million CNY | 41.91% |
| 2010 | 61.54 Million CNY | 93.87% |
| 2009 | 31.74 Million CNY | 71.64% |
| 2008 | 18.49 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 50.99 Million CNY | 2.01% |
| 2024 Q3 | 24.35 Million CNY | -52.23% |
| 2024 Q1 | 49.98 Million CNY | 447.46% |
| 2023 Q2 | 54.64 Million CNY | 25.98% |
| 2023 Q1 | 43.37 Million CNY | 256.43% |
| 2023 FY | 104.73 Million CNY | -48.92% |
| 2023 Q4 | -14.38 Million CNY | -168.21% |
| 2023 Q3 | 21.09 Million CNY | -61.4% |
| 2022 Q4 | -27.73 Million CNY | -166.44% |
| 2022 FY | 205.02 Million CNY | -9.08% |
| 2022 Q3 | 41.73 Million CNY | -45.24% |
| 2022 Q2 | 76.21 Million CNY | 62.92% |
| 2022 Q1 | 46.77 Million CNY | 71.92% |
| 2021 FY | 225.51 Million CNY | 3.36% |
| 2021 Q2 | 46.36 Million CNY | -43.02% |
| 2021 Q3 | 14.54 Million CNY | -68.62% |
| 2021 Q1 | 81.37 Million CNY | 4640.05% |
| 2021 Q4 | 27.21 Million CNY | 87.02% |
| 2020 Q2 | 54.58 Million CNY | -20.03% |
| 2020 Q1 | 68.26 Million CNY | 4035.74% |
| 2020 Q4 | -1.79 Million CNY | -121.4% |
| 2020 FY | 218.18 Million CNY | -31.57% |
| 2020 Q3 | 8.37 Million CNY | -84.65% |
| 2019 Q2 | 83.27 Million CNY | 75.47% |
| 2019 FY | 318.86 Million CNY | 17.29% |
| 2019 Q4 | -1.73 Million CNY | -103.69% |
| 2019 Q3 | 47.01 Million CNY | -43.55% |
| 2019 Q1 | 47.46 Million CNY | 10.46% |
| 2018 Q2 | 62.74 Million CNY | 62.67% |
| 2018 Q1 | 38.57 Million CNY | 39.32% |
| 2018 Q4 | 42.96 Million CNY | -19.22% |
| 2018 FY | 271.84 Million CNY | 33.02% |
| 2018 Q3 | 53.19 Million CNY | -15.22% |
| 2017 Q4 | 27.68 Million CNY | -4.14% |
| 2017 Q2 | 40.82 Million CNY | -18.76% |
| 2017 FY | 204.36 Million CNY | -2.31% |
| 2017 Q1 | 50.25 Million CNY | -13.62% |
| 2017 Q3 | 28.88 Million CNY | -29.26% |
| 2016 Q4 | 58.17 Million CNY | 60.54% |
| 2016 FY | 209.2 Million CNY | 73.01% |
| 2016 Q3 | 36.23 Million CNY | -32.74% |
| 2016 Q2 | 53.88 Million CNY | -11.53% |
| 2016 Q1 | 60.9 Million CNY | 45.53% |
| 2015 Q2 | 29.46 Million CNY | 2.53% |
| 2015 Q1 | 28.74 Million CNY | 137.1% |
| 2015 FY | 120.91 Million CNY | 44.97% |
| 2015 Q4 | 41.85 Million CNY | 100.64% |
| 2015 Q3 | 20.85 Million CNY | -29.21% |
| 2014 Q4 | 12.12 Million CNY | -24.22% |
| 2014 FY | 83.41 Million CNY | -21.88% |
| 2014 Q2 | 32.81 Million CNY | 46.03% |
| 2014 Q1 | 22.47 Million CNY | -28.31% |
| 2014 Q3 | 15.99 Million CNY | -51.26% |
| 2013 Q3 | 24.42 Million CNY | -18.41% |
| 2013 Q4 | 31.35 Million CNY | 28.37% |
| 2013 FY | 106.77 Million CNY | 7.76% |
| 2013 Q1 | 21.07 Million CNY | -30.78% |
| 2013 Q2 | 29.93 Million CNY | 42.03% |
| 2012 Q2 | 33.23 Million CNY | 31.45% |
| 2012 Q4 | 30.44 Million CNY | 200.67% |
| 2012 Q1 | 25.28 Million CNY | -9.5% |
| 2012 Q3 | 10.12 Million CNY | -69.53% |
| 2012 FY | 99.08 Million CNY | 13.45% |
| 2011 Q4 | 27.93 Million CNY | 1498.61% |
| 2011 Q3 | 1.74 Million CNY | 0.0% |
| 2011 FY | 87.33 Million CNY | 41.91% |
| 2010 FY | 61.54 Million CNY | 93.87% |
| 2009 FY | 31.74 Million CNY | 71.64% |
| 2008 FY | 18.49 Million CNY | 0.0% |